MyFinsight
Home
Blog
About
HARVARD BIOSCIENCE INC (HBIO)
HARVARD BIOSCIENCE INC (HBIO)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$595K
Free Cash flow
-$363K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Amortization of intangible asset...
Other assets
Amortization of deferred financi...
Others
Negative Cash Flow Breakdown
Net loss
Additions to property, plant and...
Capitalized software development...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-2,910
-3,424
-2,847
-1,231
Depreciation
467
443
456
425
Amortization of intangible assets
908
907
894
899
Goodwill impairment - note 4
0
0
0
0
Amortization of deferred financing costs
497
446
624
357
Stock-based compensation
380
257
459
324
Deferred income taxes and other
7
85
127
-20
Loss on pension settlement - note 8
-
-
1,233
0
Loss on extinguishment of debt
-
-
-130
-
Loss on equity securities - note 12
-
-
0
0
Accounts receivable
-58
-1,406
3,956
210
Inventories
184
1,540
-663
-637
Other assets
-781
392
-1,100
-368
Accounts payable and other liabilities
383
1,181
797
-271
Contract liabilities
-48
139
478
-234
Net cash (used in) provided by operating activities
325
-662
-96
1,084
Additions to property, plant and equipment
688
426
449
207
Capitalized software development costs
228
194
150
141
Proceeds from sale of marketable equity securities
-
-
0
0
Net cash used in investing activities
-916
-620
-599
-348
Borrowing from revolving line of credit
-
-
0
0
Borrowing from term loans
-
-
40,000
-
Repayment of revolving line of credit
-
-
12,650
0
Repayment of term debt
0
0
21,700
1,000
Payment of debt issuance costs
2
129
3,145
254
Proceeds from exercise of stock options and employee stock purchase plan
-
150
1
0
Proceeds from exercise of warrants and stock purchase plan
150
-
-
-
Taxes paid related to net share settlement of equity awards
36
30
57
24
Net cash used in financing activities
-38
-9
2,449
-1,278
Effect of exchange rate changes on cash
34
-225
43
-83
(decrease) increase in cash and cash equivalents
-595
-1,516
1,797
-625
Cash and cash equivalents at beginning of period
7,098
8,614
6,817
4,108
Cash and cash equivalents at end of period
6,503
7,098
8,614
6,817
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Amortization of intangible
assets
$908K
(-62.31%↓ Y/Y)
Other assets
-$781K
(-1373.58%↓ Y/Y)
Amortization of deferred
financing costs
$497K
(45.75%↑ Y/Y)
Depreciation
$467K
(-45.82%↓ Y/Y)
Accounts payable and
other liabilities
$383K
(-78.41%↓ Y/Y)
Stock-based compensation
$380K
(-64.55%↓ Y/Y)
Accounts receivable
-$58K
(98.21%↑ Y/Y)
Net cash (used in)
provided by operating...
$325K
(-94.34%↓ Y/Y)
Effect of exchange rate
changes on cash
$34K
(-96.50%↓ Y/Y)
Canceled cashflow
$3,149K
(decrease) increase in cash
and cash...
-$595K
(-117.85%↓ Y/Y)
Canceled cashflow
$359K
Proceeds from exercise of
warrants and stock...
$150K
Net loss
-$2,910K
(94.47%↑ Y/Y)
Inventories
$184K
(111.17%↑ Y/Y)
Contract liabilities
-$48K
(88.15%↑ Y/Y)
Deferred income taxes and
other
$7K
(-98.78%↓ Y/Y)
Net cash used in
investing activities
-$916K
(0.00%↑ Y/Y)
Net cash used in
financing activities
-$38K
(98.46%↑ Y/Y)
Canceled cashflow
$150K
Additions to property,
plant and equipment
$688K
(14.29%↑ Y/Y)
Capitalized software
development costs
$228K
(-27.39%↓ Y/Y)
something is missing
-$150K
Taxes paid related to
net share...
$36K
(-52.00%↓ Y/Y)
Payment of debt issuance
costs
$2K
(-99.54%↓ Y/Y)
Buy us a coffee